Skip to Main Content
Skip Nav Destination

Issues

Case Reports in Oncology 2019, Vol. 12, No. 3

Case Report

Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 935–943. https://doi.org/10.1159/000504568
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 928–934. https://doi.org/10.1159/000504933
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 922–927. https://doi.org/10.1159/000504929
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 918–921. https://doi.org/10.1159/000504932
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 913–917. https://doi.org/10.1159/000504937
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 909–912. https://doi.org/10.1159/000504696
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 901–908. https://doi.org/10.1159/000504569
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 896–900. https://doi.org/10.1159/000504698
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 890–895. https://doi.org/10.1159/000504337
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 885–889. https://doi.org/10.1159/000504700
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 880–884. https://doi.org/10.1159/000504699
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 872–879. https://doi.org/10.1159/000504291
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 866–871. https://doi.org/10.1159/000504473
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 861–865. https://doi.org/10.1159/000502226
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 855–860. https://doi.org/10.1159/000504339
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 845–854. https://doi.org/10.1159/000503815
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 838–844. https://doi.org/10.1159/000503817
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 834–837. https://doi.org/10.1159/000504129
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 829–833. https://doi.org/10.1159/000504019
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 820–828. https://doi.org/10.1159/000504130
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 814–819. https://doi.org/10.1159/000503858
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 807–813. https://doi.org/10.1159/000503879
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 802–806. https://doi.org/10.1159/000503816
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 796–801. https://doi.org/10.1159/000503818
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 791–795. https://doi.org/10.1159/000503419
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 777–790. https://doi.org/10.1159/000503557
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 765–776. https://doi.org/10.1159/000503417
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 755–764. https://doi.org/10.1159/000503558
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 749–754. https://doi.org/10.1159/000503418
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 742–748. https://doi.org/10.1159/000502856
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 737–741. https://doi.org/10.1159/000503096
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 728–736. https://doi.org/10.1159/000503095
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 721–727. https://doi.org/10.1159/000503171
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 715–720. https://doi.org/10.1159/000502857
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 709–714. https://doi.org/10.1159/000502858
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 704–708. https://doi.org/10.1159/000502947
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 698–703. https://doi.org/10.1159/000502949
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 693–697. https://doi.org/10.1159/000502948
Subject Area: Oncology
Case Rep Oncol (2020) 12 (3): 688–692. https://doi.org/10.1159/000502859
Close Modal

or Create an Account

Close Modal
Close Modal